Menu
Back to Journals » Vascular Health and Risk Management » Volume 4 » Issue 3
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1516)
- Volume 20, 2024 (20)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 4, 2008
Erratum
Erhardt L, Moller R, Puig JC. 2007
Vascular Health and Risk Management 2008, 4:741-741
Published Date: 6 June 2008
Diagnosis with ECG-gated MDCT of floating thrombus in aortic arch in a patient with type-A dissection
Domenico Lumia, Gianpaolo Carrafiello, Domenico Laganà, Andrea Musazzi, Andrea Giorgianni, et al
Vascular Health and Risk Management 2008, 4:735-739
Published Date: 6 June 2008
Intertester reliability of brachial artery flow-mediated vasodilation using upper and lower arm occlusion in healthy subjects
Ludmila M Cosio-Lima, Richard Seip, Paul D Thompson, Marie A Lagasse, Tabitha H Hodges
Vascular Health and Risk Management 2008, 4:731-734
Published Date: 6 June 2008
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease
Gjumrakch Aliev, Eldar Gasimov, Mark E Obrenovich, Kathryn Fischbach, Justin C Shenk, et al
Vascular Health and Risk Management 2008, 4:721-730
Published Date: 6 June 2008
Early seizures in patients with acute stroke: Frequency, predictive factors, and effect on clinical outcome
Andrea Alberti, Maurizio Paciaroni, Valeria Caso, Michele Venti, Francesco Palmerini, Giancarlo Agnelli
Vascular Health and Risk Management 2008, 4:715-720
Published Date: 6 June 2008
Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease
Ioannis Kallikazaros, Costas Tsioufis, Panagiotis Zambaras, Ioannis Skiadas, Marina Toutouza, et al
Vascular Health and Risk Management 2008, 4:705-714
Published Date: 6 June 2008
Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation
Marie-Louise Edvinsson, Sven E Andersson, Cang-Bao Xu, Lars Edvinsson
Vascular Health and Risk Management 2008, 4:699-704
Published Date: 6 June 2008
Five-year incidence of type 2 diabetes mellitus among cardiovascular disease-free Greek adults: Findings from the ATTICA study
Demosthenes B Panagiotakos, Christos Pitsavos, Yannis Skoumas, Yannis Lentzas, Christodoulos Stefanadis
Vascular Health and Risk Management 2008, 4:691-698
Published Date: 6 June 2008
The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
Joerg Tautenhahn, Ralf Lobmann, Brigitte Koenig, Zuhir Halloul, Hans Lippert, Thomas Buerger
Vascular Health and Risk Management 2008, 4:683-689
Published Date: 6 June 2008
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
Bimal V Patel, R Scott Leslie, Patrick Thiebaud, Michael B Nichol, Simon SK Tang, et al
Vascular Health and Risk Management 2008, 4:673-681
Published Date: 6 June 2008
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
Claudio Borghi, Arrigo FG Cicero, Ettore Ambrosioni
Vascular Health and Risk Management 2008, 4:665-671
Published Date: 6 June 2008
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
Eduardo Pimenta, Suzanne Oparil
Vascular Health and Risk Management 2008, 4:653-654
Published Date: 6 June 2008
Measurement of endothelial function and its clinical utility for cardiovascular risk
Mo Al-Qaisi, Rajesh K Kharbanda, Tarun K Mittal, Ann E Donald
Vascular Health and Risk Management 2008, 4:647-652
Published Date: 6 June 2008
Antiplatelet drugs in cardiological practice: Established strategies and new developments
Florian Krötz, Hae-Young Sohn, Volker Klauss
Vascular Health and Risk Management 2008, 4:637-645
Published Date: 6 June 2008
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation
Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al
Vascular Health and Risk Management 2008, 4:629-636
Published Date: 6 June 2008
Perioperative hypertension management
Joseph Varon, Paul E Marik
Vascular Health and Risk Management 2008, 4:615-627
Published Date: 6 June 2008
Cardiovascular co-morbidity in rheumatic diseases
Carl Turesson, Lennart TH Jacobsson, Eric L Matteson
Vascular Health and Risk Management 2008, 4:605-614
Published Date: 6 June 2008
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
Dimitar Divchev, Bernhard Schieffer
Vascular Health and Risk Management 2008, 4:597-604
Published Date: 6 June 2008
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Camelia R Ban, Stephen M Twigg
Vascular Health and Risk Management 2008, 4:575-596
Published Date: 6 June 2008
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
Kjeld Hermansen, Lene Sundahl Mortensen, Marie-Louise Hermansen
Vascular Health and Risk Management 2008, 4:561-574
Published Date: 6 June 2008
Drug-eluting stents in the management of peripheral arterial disease
Marc Bosiers, Catherine Cagiannos, Koen Deloose, Jürgen Verbist, Patrick Peeters
Vascular Health and Risk Management 2008, 4:553-559
Published Date: 6 June 2008
Early vascular aging (EVA): consequences and prevention
Peter M Nilsson
Vascular Health and Risk Management 2008, 4:547-552
Published Date: 6 June 2008
Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases
Ben van Steenkiste, Richard Grol, Trudy van der Weijden
Vascular Health and Risk Management 2008, 4:535-545
Published Date: 6 June 2008
Relative safety profiles of high dose statin regimens
Carlos Escobar, Rocio Echarri, Vivencio Barrios
Vascular Health and Risk Management 2008, 4:525-533
Published Date: 6 June 2008
Relaxin as a natural agent for vascular health
Daniele Bani
Vascular Health and Risk Management 2008, 4:515-524
Published Date: 6 June 2008
Treprostinil for pulmonary hypertension
Nika Skoro-Sajer, Irene Lang, Robert Naeije
Vascular Health and Risk Management 2008, 4:507-513
Published Date: 6 June 2008
Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
Ravi K Ramana, Bruce E Lewis
Vascular Health and Risk Management 2008, 4:493-505
Published Date: 6 June 2008
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet
Serge Halimi, Anja Schweizer, Biljana Minic, James Foley, Sylvie Dejager
Vascular Health and Risk Management 2008, 4:481-492
Published Date: 6 June 2008